SlideShare una empresa de Scribd logo
1 de 118
β-lactam antibiotics
Dr.Shefali Jaiswal
1
Contents
• Introduction
• History
• Classification
• Mode of action
• Bacterial cell structure
• Beta-lactum drugs –
Classification
Structure
Mechanism of action
Penicillin
2
Cephalosporin
Carbapenem
Monobactum
Beta-lactum inhibitors
• Resistance
• Applied aspect
• Conclusion
• Bibilography
3
Introduction
4
• Dentists prescribe medications for the
management of a number of oral conditions,
mainly orofacial infections.
• Since most human orofacial infections
originate from odontogenic infections, the
prescribing of antibiotics by dental practitioners
has become an important aspect of dental
practice.
• For this reason, antibiotics account for the vast
majority of medicines prescribed by dentists.
5
Greek word
Anti - against
Bios - life
Definition:
“Antibiotics are substances produced by
microorganisms, which selectively suppress the
growth of or kill other micro-organisms at very low
concentrations.”
6
• The term antibiotic was given by Waksman in
1941.
• He described antibiotics as chemical
substances produced by microorganisms
having the property of inhibiting the growth or
destroying other microorganisms in high
dilution
• Chemotherapy treatment of systemic infections
with specific drugs that selectively suppress the
infecting microorganism without significantly
affecting the host.
7
History
8
• Early History
During ancient times;
• Greeks and Indians used moulds and other
plants to treat infections.
• In Greece and Serbia, mouldy bread was
traditionally used to treat wounds and
infections.
• Warm soil was used in Russia by peasants to
cure infected wounds.
• Sumerian doctors gave patients beer soup
mixed with turtle shells and snake skins.
9
• Babylonian doctors healed the eyes using a
mixture of frog bile and sour milk.
• Sri Lankan army used oil cake (sweetmeat) to
server both as desiccant and antibacterial.
10
MODERN HISTORY
• 1640 - John Parkington recommended using
mould for treatment in his book on
pharmacology.
• 1870 - Sir John Scott Burdon-Sanderson
observed that culture fluid covered with mould
did not produce bacteria.
• 1871 - Joseph Lister experimented with the
antibacterial action on human tissue on what
he called Penicillium glaucium.
• 1875 - John Tyndall explained antibacterial
action of the Penicillium fungus to the Royal
Society.
11
• 1877 - Louis Pasteur postulated that bacteria
could kill other bacteria (anthrax bacilli).
• 1897 - Ernest Duchesne healed infected guinea
pigs from typhoid using mould (Penicillium
glaucium).
• 1928 - Sir Alexander Fleming discovered
enzyme lysozyme and the antibiotic substance
penicillin from the fungus Penicillium notatum.
• 1932- Gerhard Domagk discovered
Sulfonamidochrysoidine (Prontosil ).
12
• During 1940's and 50's streptomycin,
chloramphenicol, and tetracycline were
discovered and Selman Waksman used the
term "antibiotics" to describe them (1942).
13
Sir Alexander Fleming
• Sir Alexander Fleming, a Scottish biologist,
defined new horizons for modern antibiotics
with his discoveries of enzyme lysozyme (1921)
and the antibiotic substance penicillin (1928).
• It was in 1928 when he observed while
experimenting on influenza virus that a
common fungus, Penicillium notatum had
destroyed bacteria in a staphylococcus culture
plate.
14
• Upon subsequent investigation, he found out
that mould juice had developed a bacteria-free
zone which inhibited the growth of
staphylococci.
• This newly discovered active substance was
effective even when diluted up to 800 times.
• He named it penicillin.
15
Classification
16
Classification of Antibiotics
Based on
mode of Action
Bacteriostatic Bactericidal
Based on their
spectrum of
action
Broad-spectrum
Narrow
Spectrum
17
Spectrum of Activity:
1.) Narrow Spectrum:
e.g. Penicillin G, Streptomycin,
Erythromycin.
2.) Broad Spectrum:
e.g. Tetracyclines, Chloramphenicol.
18
Types of Antibiotics
(Based on their mode of action)
Bacteriostatic
Antibiotics
• Tetracyclines
• Spectinomycin
• Sulphonamides
• Macrolides
• Chloramphenicol
• Trimethoprim
Bactericidal Antibiotics
• Penicillins
• Cephalosporins
•Fluoroquinolones
(Ciprofloxacin)
• Glycopeptides (Vancomycin)
• Monobactams
• Carbapenems
19
Types of Antibiotics
(Based on their structural similarities)
20
Antibiotics: Mode of Action
21
• Inhibitors of DNA synthesis
• Inhibitors of bacterial protein synthesis
• Inhibitors of bacterial cell wall synthesis
• Interference with metabolism
• Impairment of nucleic acids
Bacterial Cell structure
22
Gram positive vs. Gram negative
bacteria
23
24
25
26
• Peptidoglycan is a carbohydrate composed of
alternating units of NAMA and NAGA.
• The NAMA units have a peptide side chain
which can be cross linked from the L-Lys
residue to the terminal D-Ala-D-Ala link on a
neighboring NAMA unit.
27
28
29
•The cross linking reaction is
catalyzed by a class of
transpeptidases known as penicillin
binding proteins
•A critical part of the process is the
recognition of the D-Ala-D-Ala
sequence of the NAMA peptide
side chain by the PBP. Interfering
with this recognition disrupts the
cell wall synthesis.
•β-lactams mimic the structure of
the D-Ala-D-Ala link and bind to the
active site of PBPs, disrupting the
cross-linking process.
Transpeptidase Enzyme
30
Transpeptidation mechanism
31
Beta–lactam Drugs
32
Beta-Lactam Antibiotics
β-lactam
ring
•Contains a beta-lactam ring in their molecular structures.
•Nitrogen is attached to the beta carbon relative to the
carbonyl ring and hence the name.
33
Classification
•Penicillins
•Cephalosporins
•Other β-Lactam drugs
--Cephamycins
--Carbapenems
--Oxacephalosporins
--β-Lactamase inhibitors
--Monolactams
34
Beta-Lactam Structure
35
How do they work?
1. The β-lactam binds to Penicillin Binding
Protein (PBP).
2. PBP is unable to crosslink peptidoglycan
chains.
3. The bacteria is unable to synthesize a stable
cell wall.
4. The bacteria is lysed.
36
Mechanism of β-Lactam Drugs
• The amide of the β-lactam ring is unusually
reactive due to ring strain and a conformational
arrangement which does not allow the lone pair of
the nitrogen to interact with the double bond of the
carbonyl.
• β-Lactams acylate the hydroxyl group on the serine
residue of PBP active site in an irreversible
manner.
• This reaction is further aided by the oxyanion hole,
which stabilizes the tetrahedral intermediate and
thereby reduces the transition state energy.
37
Mechanism of β-Lactam Drugs
The hydroxyl attacks the amide and forms a tetrahedral
intermediate.
38
Mechanism of β-Lactam Drugs
The tetrahedral intermediate collapses, the amide bond is broken,
and the nitrogen is reduced.
39
Mechanism of β-Lactam Drugs
The PBP is now covalently bound by the drug and cannot perform
the cross linking action.
40
Penicillin
41
Natural Penicillin
42
Penicillin G
• It is a drug of choice for infections caused by streptococci,
meningococci, enterococci, penicillin - susceptible pneumococci,
non-β-lactamase-producing staphylococci, T. pallidum and many
other spirochetes, clostridium species, actinomyces, and other
Gram - positive rods and non-β-lactamase-producing Gram-
negative anaerobic organisms.
43
Adverse effects
•The main hazard with the penicillins is allergic reaction.
•These include itching, rashes (eczematous or urticarial), fever, and
angioedema.
•Rarely (about 1 in 10 000) there is anaphylactic shock which can be
fatal (about 1 in 50 000 – 100 000 treatment courses).
44
• Allergies are least likely when penicillins are given orally and
most likely with local application.
• Metabolic opening of the β-lactam ring creates a highly
reactive penicilloyl Group which polymerizes and binds with
tissue Proteins to form the major antigenic determinant.
• The anaphylactic reaction involves specific IgE
antibodies which can be detected in the plasma of susceptible
persons. 45
DOSES
46
PENICILLIN G
1. Sod. Penicillin G (crystalline penicillin) injection.
0.5-5 MU i.m/i.v 6-12 hourly. Available as dry
powder to be dissolves with sterile water at the
time of injection.
2. Procaine penicillin G inj.
0.5-5 MU i.m/i.v 12-24 hourly.
3. Benzathine penicillin G
o.6-2.4 MU i.m. every 2-4 weeks as aqueous
suspensions.
47
Penicillin V (Phenoxymethylpenicillin)
EFFECTIVE AGAINST:
• Gram positive + Less effective
against Gram negative
bacteria
TREATMENT FOR:
• Tonsillitis
• Anthrax
• Rheumatic fever
• Streptococcal skin infections
CHARACTERISTICS:
• Narrow spectrum
• Should be given orally
• Prone to beta-lactamase 48
Jarisch – Herxheimer Reaction
• Pencillin is injected into a syphilitic patient.
• May produce shivering, fever, myalgia,
exacerbation of the lesions and even vascular
collapse.
• Occurs due to sudden release of spirochetal
lytic products.
• Effects last for 12 – 72 hours.
• Intake of Aspirin and sedation cause relief of
symptoms.
49
Amino-Penicillin
Ampicillin R=Ph
Amoxicillin R= Ph-OH
50
Ampicillin
EFFECTIVE AGAINST:
• Gram positive + Gram
negative bacteria
TREATMENT FOR:
• Ear infection
• Sinusitis
• Urinary tract infections
• Meningitis
CHARACTERISTICS:
• Broad spectrum
• Can be given orally and
parenterally
• Prone to beta-
lactamase
Ampicillin
Sulbactam
+
ll
Unasyn 51
Amoxicillin
EFFECTIVE AGAINST:
• Gram positive + Gram
negative bacteria
TREATMENT FOR:
• Skin infection
• Sinusitis
• Urinary tract infections
• Streptococcal pharyngitis
CHARACTERISTICS:
• Broad spectrum
• Can be given orally and
parenterally
• Prone to beta-lactamase
SIDE-EFFECTS:
• Rash, diarrhea, vomiting,
nausea, edema, stomatitis,
and easy fatigue.
Amoxicillin
Clavulanic Acid
+
ll
Augmentin
52
Anti-Staphylococcal Penicillin
53
Methicillin
EFFECTIVE AGAINST:
• Gram positive bacteria
TREATMENT FOR:
• Cellulitis
• Also for life threating diseases
such as pneumonia,
endocarditis, bacteremia and
meningitis.
CHARACTERISTICS:
• Very narrow Spectrum
• Should be given parenterally
SIDE-EFFECT:
• Interstitial nephritis 54
Oxacillin
EFFECTIVE AGAINST:
• Gram positive bacteria
TREATMENT AGAINST:
• penicillin-resistant Staphylococcus
aureus
CHARACTERISTICS:
• Very narrow Spectrum
• Should be given parenterally
SIDE-EFFECT:
• Hypersensitivity and local reactions
• In high doses, renal, hepatic, or
nervous system effects can occur
55
Nafcillin
EFFECTIVE AGAINST:
• Gram positive bacteria
TREATMENT AGAINST:
• Staphylococcal infections
CHARACTERISTICS:
• Very narrow Spectrum
• Should be given parenterally
SIDE-EFFECT:
• Allergic reactions
• Nausea and vomiting
• Abdominal pain
56
Cloxacillin
EFFECTIVE AGAINST:
• Staphylococci that produce
beta-lactamase
CHARACTERISTICS:
• Very narrow Spectrum
• Should be given orally
SIDE-EFFECT:
• Allergic reaction
57
Dicloxacillin
EFFECTIVE AGAINST:
• Gram positive bacteria +
Staphylococci that produce beta-
lactamase
CHARACTERISTICS:
• Very narrow Spectrum
• Should be given orally
SIDE-EFFECT:
• Allergic reaction
• Diarrhoea, nausea, rash, urticaria
pain and inflammation at injection
site
58
Flucloxacillin
EFFECTIVE AGAINST:
• Gram positive bacteria +
Staphylococci that produce beta-
lactamase
CHARACTERISTICS:
• Very narrow Spectrum
• Should be given orally
SIDE-EFFECT:
• Allergic reaction
• Diarrhoea, nausea, rash, urticaria
pain and inflammation at injection
site
59
Anti-Pseudomonal Penicillin
60
Piperacillin
EFFECTIVE AGAINST:
• Gram positive +Gram negative
CHARACTERISTICS:
• Extended Spectrum
• Should be given
by intravenous or intramuscular injection
SIDE-EFFECT:
• Hypersensitivity
• Gastrointestinal disorders
• Renal disorders
*Piperacillin+Tazobactam=Zosyn
61
Carbenicillin
EFFECTIVE AGAINST:
• Gram negative + Limited Gram
positive
TREATMENT FOR:
• Urinary tract infections
CHARACTERISTICS:
• Highly soluble in water and acid-
labile
SIDE-EFFECT:
• High doses can cause bleeding
• Hypokalemia
62
Ticarcillin
EFFECTIVE AGAINST:
• Mainly gram negative bacteria
particularly Pseudomonas aeruginosa
TREATMENT FOR:
• Stenotrophomonas maltophilia
infections
CHARACTERISTICS:
SIDE-EFFECT:
• Diarrhoea
• Bleeding
• Fever
• Fainting
63
Cephalosporin
64
65
• These has been conventionally classified into four generations
based on Generation system.
• This is based on chronological sequence of development, but
more importantly, takes into consideration the overall
antibacterial spectrum as well as potency.
• First-generation cephalosporins are predominantly active
against Gram-positive bacteria, and successive generations
have increased activity against Gram-negative bacteria (albeit
often with reduced activity against Gram-positive organisms).
66
CEPHALOSPORINS
•The nucleus of the cephalosporins, 7-aminocephalo- sporanic acid,
bears a close resemblance to 6-amino- penicillanic acid.
•The intrinsic antimicrobial activity of natural cephalosporins is low,
but the attachment of various R1 and R2 groups has yielded
hundreds of potent compounds of low toxicity.
•Cephalosporins can be classified into four major groups or
generations, depending mainly on the spectrum of their antimicrobial
activity. 67
7-Aminocephalosporanic acid nucleus
68
Cephalosporins are similar to penicillins, but more stable
to many bacterial beta-lactamases and therefore have a
broader spectrum of activity.
Klebsiella pneumoniae
69
• However, strains of E. coli and Klebsiella species
expressing extended-spectrum beta-lactamases that
can hydrolyze most cephalosporins are becoming a
problem.
• Cephalosporins are not active against enterococci
and Listeria monocytogenes.
70
First Generation Cephalosporins
Cefalothin Cefalexin
Cefadroxil Cefazolin
71
• These drugs are very active against Gram-positive cocci
(such as pneumococci, streptococci, and Staphylococci).
Cephalosporins are not active against methicillin-
resistant strains of staphylococci.
72
• E. coli, K. pneumoniae, and P. mirabilis are often
sensitive. Anaerobic cocci (e.g., peptococcus,
peptostreptococcus) are usually sensitive, but
Bacteroides fragilis is not.
73
Cefalexin p.o.
74
Although the first-generation cephalosporins are broad
spectrum and relatively nontoxic, they are rarely the
drug of choice for any infection.
75
Second Generation Cephalosporins
Cefuroxime(Oral) Cefotetan
76
• In general, they are active against organisms inhibited by first-
generation drugs, but in addition they have extended Gram-
negative coverage.
• Klebsiellae (including those resistant to cefalothin) are usually
sensitive. Cefamandole, cefuroxime, and cefaclor are active
against H. influenzae but not against serratia or B. fragilis.
77
• In contrast, cefoxitin, and cefotetan are active against B. fragilis
and some serratia strains but are less active against H.
influenzae. As with first-generation agents, none is active against
enterococci or P. aeruginosa.
78
Cefuroxime
• Zinacef™
79
Cefoxitin
80
Third Generation Cephalosporins
Cefotaxime Ceftriaxone
Ceftazidime 81
• Compared with second-generation agents, these drugs have
expanded Gram-negative coverage.
• Third-generation drugs are active against Citrobacter, Serratia
marcescens, and Providencia.
• They are also effective against β-lactamase-producing strains
of Haemophilus and Neisseria.
82
Like the second-generation drugs, third-generation
cephalosporins are hydrolyzable by constitutively
produced beta-lactamase, and they are not reliably active
against enterobacter species.
83
Third-generation cephalosporins are used to treat a wide
variety of serious infections caused by organisms that
are resistant to most other drugs.
84
Ceftriaxone
85
Fourth Generation Cephalosporins
Cefepime
86
Carbapenem
87
• Carbapenems are a class of beta-lactam antibiotics with a broad
spectrum of antibacterial activity.
• They have a structure that renders them highly resistant to beta-
lactamases.
• Carbapenem antibiotics were originally developed from
thienamycin, a naturally-derived product of Streptomyces cattleya.
88
Carbapenems common uses
• Imipenem
• Broad spectrum, covers Gram-positive, Gram-negative
(including ESBL-producing strains), Pseudomonas and
anaerobes
• Meropenem
• Less seizure-inducing potential, can be used to treat CNS
infections
• Ertapenem
• Lacks activity against Acinetobacter and Pseudomonas
• Has limited activity against penicillin-resistant pneumococci
89
Imipenem
EFFECTIVE AGAINST:
• Aerobic and anaerobic, Gram
positive and gram negative
bacteria
CHARACTERISTICS:
• Broad Spectrum
• Intravenous
• Resistant to beta-lactamase
enzymes
SIDE-EFFECT:
• Seizuregenic at high doses
90
Meropenem
EFFECTIVE AGAINST:
• Aerobic and anaerobic, Gram
positive and gram negative
bacteria
CHARACTERISTICS:
• Ultra Broad Spectrum
• Intravenous
• Resistant to beta-lactamase
enzymes
SIDE-EFFECT:
• Diarrhoea
• Vomiting
• headache
91
Ertapenem
EFFECTIVE AGAINST:
• Gram positive and gram negative
bacteria
CHARACTERISTICS:
• Broad Spectrum
• Intravenous
• Resistant to beta-lactamase
enzymes
• Not active against MRSA
SIDE-EFFECT:
• Convulsions
• Seizures
• headache
92
Monobactam
93
Aztreonam
EFFECTIVE AGAINST:
• Gram positive +Gram
negative+Anaerobic bacteria
CHARACTERISTICS:
• Broad Spectrum
• Intravenous
• Resistant to beta-lactamase
enzymes
• Not active against MRSA
SIDE-EFFECT:
• Diarrhoea
• Nausea
• Vomiting
94
BETA-LACTAMASE INHIBITORS
• Resemble β-lactam antibiotic structure.
•
• Bind to β-lactamase and protect the antibiotic from destruction.
• Most successful when they bind the β-lactamase irreversibly.
• Three important in medicine:
• Clavulanic Acid
• Sulbactam
• Tazobactam 95
Beta–lactam Resistance
96
Resistance-The Global Battle.!!!
What is Resistance?
•Drug resistance refers to unresponsiveness of a
microorganism to an antimicrobial agent.
•Drug resistance are of two types:
---Natural Resistance
---Acquired Resistance
97
Natural Resistance
• Some microbes have always been resistant to certain anti-
microbial agent.
• They lack the metabolic process or the target side that is
affected by particular drug.
E.g: Gram negative bacilli are normally unaffected by Penicillin G.
• M. tuberculosis is insensitive to Tetracyclines.
• This type of resistance does not pose significant clinical
problem.
98
Acquired Resistance
• It is the development of resistance by an organism which was
sensitive before due to the use of antimicrobial agent over a
period of time.
• This can happen with any microbe and is a major clinical
problem.
• However, the development of resistance is dependent on the
microorganism as well as the drug.
99
MECHANISMS FOR ACQUIRING
RESISTANCE
100
APPLIED ASPECT
1. Penicillin hypersensitivity
2. Skin eruptions
• Anaphylaxis:
Anaphylaxis occurs in about 1 in 10,000 patients using
penicillin, accounting for approximately 300 deaths per
year in the United States.
.
• Management:
While the triggering agent of an acute allergic reaction is variable,
the approach to handling the emergency is similar in most cases.
The dentist's primary responsibility in an allergic emergency is to
stabilize the patient until he or she can be transferred to an
emergency facility or until assistance arrives.
103
Guidelines for sequencing of antibiotic
therapy
• Supplemental, subgingivally applied, broad-spectrum antiseptic
agents may be used.
• Periodontal abscesses may develop if systemic antibiotics are
administered without mechanical debridement.
104
Prescription of drugs
• Prescription drugs are the fastest growing component of personal
health expenditures.
• Contributing to this are the increased FDA approvals of expensive
and new drugs.
• Antibiotics should be prescribed judiciously rather than zealously.
• Judicious use of antimicrobial therapy mandates restrained rather
than indiscriminate prescribing.
105
Antibiotic sensitivity cultures…
• Aim is to measure susceptibility of an isolate two range of
antibiotics at the individual patient level for effective prescribing
but also to assess emerging bacterial resistance patterns.
106
Overprescribing….
• Excessive prescribing or over prescribing unnecessarily exposes
the patient to increased financial costs as well as substantial risk
of antibiotic complications and increased number of antibiotic
resistant organisms in the general population.
Eg: For healthy patients prophylactic antibiotics for routine
periodontal surgery or extractions.
107
Wrong choice of antibiotics
• Prescribing a broad spectrum antibiotic when a narrow spectrum
one would be sufficient or prescribing unnecessarily long courses
of antibiotic therapy increases the risk of resistant bacterial strain
development.
• Bacterial resistance to a single antibiotic or to multiple groups
frequently results from genetic transfer abilities of bacteria which
allow them to create pathogens with antibiotic resistant genes.
108
Antibiotics in periodontal therapy
Conditions that may call for systemic antimicrobial periodontal
therapy are:
• Medical conditions that predispose patients to periodontitis.
• Acute periodontal infections (periodontal abscess, acute
necrotizing ulcerative gingivitis/periodontitis).
109
Antibiotics in endodontic therapy
• It has been well documented that infected root canals are
polymicrobial in nature with several predominant anaerobic
microorganisms.
• The key to successful management of infections of endodontic
origin is the chemomechanical debridement of the infected root
canal system and drainage from both soft and hard tissues.
110
Antibiotics for oral and
maxillofacial infections
Antibiotic prophylaxis
• It is not possible to make recommendations regarding
antibiotic prophylaxis for all clinical situations.
• Antibiotic prophylaxis is the administration of antibiotics
to patients who have no known infection for the purpose
of preventing microbial colonozation and reducing the
potential for post operative complications.
111
Breast feeding
112
113
114
• They play a very important role in :
• Patients at risk of bactereamia-induced infections.
• Patients with Pregnancy
• Breast feeding patients
• Secondary infections
• Or any other medically compromised patients .
115
• It is therefore important for the clinicians to have proper
knowledge, ability monitor the effectiveness of prescribed
antibiotics and consider changing the drug or the method of
therapeutic management with antibiotics.
116
Bibliography
• K.D. TRIPATHI text book of pharmacology.
• Antibiotic and antimicrobial use in dental practice: 2nd edn,
Michael G. Newman.
• Pharmacology an introductory text: Mary Kaye Asperheim, 6th
edn.
• Text book of pharmacology, 1st edn, H.L. Sharma.
• Anti microbial therapy in periodontics. Slots J.
• Text book of Peridontology: Carranza.
117
118

Más contenido relacionado

La actualidad más candente

Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...Dr. Ravi Sankar
 
Cephalosporins & other β lactam antibiotics
Cephalosporins & other β lactam  antibioticsCephalosporins & other β lactam  antibiotics
Cephalosporins & other β lactam antibioticsFarazaJaved
 
beta lactam antibiotics
beta lactam antibioticsbeta lactam antibiotics
beta lactam antibioticsRavish Yadav
 
Monobactam antibiotics
Monobactam antibioticsMonobactam antibiotics
Monobactam antibioticsRyma Chohan
 
2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agents2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agentsJagirPatel3
 
Chloramphenicol
ChloramphenicolChloramphenicol
Chloramphenicolraj kumar
 
Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...
Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...
Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...Ravi Kant Agrawal
 
Beta lactamase inhibitors
Beta lactamase inhibitorsBeta lactamase inhibitors
Beta lactamase inhibitorsJagirPatel3
 
Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Areej Abu Hanieh
 

La actualidad más candente (20)

Macrolide antibiotics
Macrolide antibioticsMacrolide antibiotics
Macrolide antibiotics
 
Beta Lactam Antibiotics
Beta Lactam Antibiotics Beta Lactam Antibiotics
Beta Lactam Antibiotics
 
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
 
Macrolides
MacrolidesMacrolides
Macrolides
 
Aminoglycosides.pptx
Aminoglycosides.pptxAminoglycosides.pptx
Aminoglycosides.pptx
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Macrolide antibiotics
Macrolide antibioticsMacrolide antibiotics
Macrolide antibiotics
 
Cephalosporins & other β lactam antibiotics
Cephalosporins & other β lactam  antibioticsCephalosporins & other β lactam  antibiotics
Cephalosporins & other β lactam antibiotics
 
beta lactam antibiotics
beta lactam antibioticsbeta lactam antibiotics
beta lactam antibiotics
 
Monobactam antibiotics
Monobactam antibioticsMonobactam antibiotics
Monobactam antibiotics
 
Tetracycline and Chloramphenicol
Tetracycline and ChloramphenicolTetracycline and Chloramphenicol
Tetracycline and Chloramphenicol
 
2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agents2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agents
 
Antibiotic Penicillin
Antibiotic PenicillinAntibiotic Penicillin
Antibiotic Penicillin
 
Chloramphenicol
ChloramphenicolChloramphenicol
Chloramphenicol
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibiotics
 
Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...
Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...
Antibiotics inhibiting protein synthesis 3 chloramphenicol and macrolides 03 ...
 
Beta lactamase inhibitors
Beta lactamase inhibitorsBeta lactamase inhibitors
Beta lactamase inhibitors
 
Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Cephalosporins - Pharmacology
Cephalosporins - Pharmacology
 
Penicillins (VK)
Penicillins (VK)Penicillins (VK)
Penicillins (VK)
 

Similar a β-lactam antibiotics: A review of their classification, mode of action and clinical uses

Anti Tubercular and anti leprotic agents.pdf
Anti Tubercular and anti leprotic agents.pdfAnti Tubercular and anti leprotic agents.pdf
Anti Tubercular and anti leprotic agents.pdfImtiyaz60
 
Antibiotics acting on cell wall 1 penicillins 03-05-2018
Antibiotics acting on cell wall 1   penicillins 03-05-2018Antibiotics acting on cell wall 1   penicillins 03-05-2018
Antibiotics acting on cell wall 1 penicillins 03-05-2018Ravi Kant Agrawal
 
Antibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistryAntibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistryParikshit Kadam
 
Beta lactams- History, Current Trend and Recent Advances
Beta  lactams- History, Current Trend and Recent AdvancesBeta  lactams- History, Current Trend and Recent Advances
Beta lactams- History, Current Trend and Recent AdvancesAnkitaNegi32
 
Chemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxChemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxebulcha100
 
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.pptBETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.pptAbdelrhman Abooda
 
Antibiotic in endodontic
Antibiotic in endodonticAntibiotic in endodontic
Antibiotic in endodonticms khatib
 
Novel antibiotics
Novel antibioticsNovel antibiotics
Novel antibioticsHimikaRathi
 

Similar a β-lactam antibiotics: A review of their classification, mode of action and clinical uses (20)

1. MC III UNIT 1.pptx
1. MC III UNIT 1.pptx1. MC III UNIT 1.pptx
1. MC III UNIT 1.pptx
 
Anti Tubercular and anti leprotic agents.pdf
Anti Tubercular and anti leprotic agents.pdfAnti Tubercular and anti leprotic agents.pdf
Anti Tubercular and anti leprotic agents.pdf
 
Antibiotics acting on cell wall 1 penicillins 03-05-2018
Antibiotics acting on cell wall 1   penicillins 03-05-2018Antibiotics acting on cell wall 1   penicillins 03-05-2018
Antibiotics acting on cell wall 1 penicillins 03-05-2018
 
Antibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistryAntibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistry
 
Beta lactams- History, Current Trend and Recent Advances
Beta  lactams- History, Current Trend and Recent AdvancesBeta  lactams- History, Current Trend and Recent Advances
Beta lactams- History, Current Trend and Recent Advances
 
Penicillin
PenicillinPenicillin
Penicillin
 
Ab
AbAb
Ab
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Pharmacology II Chapter 1 ppt -.pptx
Pharmacology II Chapter 1 ppt -.pptxPharmacology II Chapter 1 ppt -.pptx
Pharmacology II Chapter 1 ppt -.pptx
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Chemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxChemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptx
 
31.ppt
31.ppt31.ppt
31.ppt
 
31.ppt
31.ppt31.ppt
31.ppt
 
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.pptBETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
 
Antibiotic in endodontic
Antibiotic in endodonticAntibiotic in endodontic
Antibiotic in endodontic
 
Chemotherapy seyoum
Chemotherapy seyoumChemotherapy seyoum
Chemotherapy seyoum
 
Novel antibiotics
Novel antibioticsNovel antibiotics
Novel antibiotics
 
1.sulfonamide final
1.sulfonamide final1.sulfonamide final
1.sulfonamide final
 

Último

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 

Último (20)

Epilepsy
EpilepsyEpilepsy
Epilepsy
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 

β-lactam antibiotics: A review of their classification, mode of action and clinical uses

  • 2. Contents • Introduction • History • Classification • Mode of action • Bacterial cell structure • Beta-lactum drugs – Classification Structure Mechanism of action Penicillin 2
  • 3. Cephalosporin Carbapenem Monobactum Beta-lactum inhibitors • Resistance • Applied aspect • Conclusion • Bibilography 3
  • 5. • Dentists prescribe medications for the management of a number of oral conditions, mainly orofacial infections. • Since most human orofacial infections originate from odontogenic infections, the prescribing of antibiotics by dental practitioners has become an important aspect of dental practice. • For this reason, antibiotics account for the vast majority of medicines prescribed by dentists. 5
  • 6. Greek word Anti - against Bios - life Definition: “Antibiotics are substances produced by microorganisms, which selectively suppress the growth of or kill other micro-organisms at very low concentrations.” 6
  • 7. • The term antibiotic was given by Waksman in 1941. • He described antibiotics as chemical substances produced by microorganisms having the property of inhibiting the growth or destroying other microorganisms in high dilution • Chemotherapy treatment of systemic infections with specific drugs that selectively suppress the infecting microorganism without significantly affecting the host. 7
  • 9. • Early History During ancient times; • Greeks and Indians used moulds and other plants to treat infections. • In Greece and Serbia, mouldy bread was traditionally used to treat wounds and infections. • Warm soil was used in Russia by peasants to cure infected wounds. • Sumerian doctors gave patients beer soup mixed with turtle shells and snake skins. 9
  • 10. • Babylonian doctors healed the eyes using a mixture of frog bile and sour milk. • Sri Lankan army used oil cake (sweetmeat) to server both as desiccant and antibacterial. 10
  • 11. MODERN HISTORY • 1640 - John Parkington recommended using mould for treatment in his book on pharmacology. • 1870 - Sir John Scott Burdon-Sanderson observed that culture fluid covered with mould did not produce bacteria. • 1871 - Joseph Lister experimented with the antibacterial action on human tissue on what he called Penicillium glaucium. • 1875 - John Tyndall explained antibacterial action of the Penicillium fungus to the Royal Society. 11
  • 12. • 1877 - Louis Pasteur postulated that bacteria could kill other bacteria (anthrax bacilli). • 1897 - Ernest Duchesne healed infected guinea pigs from typhoid using mould (Penicillium glaucium). • 1928 - Sir Alexander Fleming discovered enzyme lysozyme and the antibiotic substance penicillin from the fungus Penicillium notatum. • 1932- Gerhard Domagk discovered Sulfonamidochrysoidine (Prontosil ). 12
  • 13. • During 1940's and 50's streptomycin, chloramphenicol, and tetracycline were discovered and Selman Waksman used the term "antibiotics" to describe them (1942). 13
  • 14. Sir Alexander Fleming • Sir Alexander Fleming, a Scottish biologist, defined new horizons for modern antibiotics with his discoveries of enzyme lysozyme (1921) and the antibiotic substance penicillin (1928). • It was in 1928 when he observed while experimenting on influenza virus that a common fungus, Penicillium notatum had destroyed bacteria in a staphylococcus culture plate. 14
  • 15. • Upon subsequent investigation, he found out that mould juice had developed a bacteria-free zone which inhibited the growth of staphylococci. • This newly discovered active substance was effective even when diluted up to 800 times. • He named it penicillin. 15
  • 17. Classification of Antibiotics Based on mode of Action Bacteriostatic Bactericidal Based on their spectrum of action Broad-spectrum Narrow Spectrum 17
  • 18. Spectrum of Activity: 1.) Narrow Spectrum: e.g. Penicillin G, Streptomycin, Erythromycin. 2.) Broad Spectrum: e.g. Tetracyclines, Chloramphenicol. 18
  • 19. Types of Antibiotics (Based on their mode of action) Bacteriostatic Antibiotics • Tetracyclines • Spectinomycin • Sulphonamides • Macrolides • Chloramphenicol • Trimethoprim Bactericidal Antibiotics • Penicillins • Cephalosporins •Fluoroquinolones (Ciprofloxacin) • Glycopeptides (Vancomycin) • Monobactams • Carbapenems 19
  • 20. Types of Antibiotics (Based on their structural similarities) 20
  • 21. Antibiotics: Mode of Action 21 • Inhibitors of DNA synthesis • Inhibitors of bacterial protein synthesis • Inhibitors of bacterial cell wall synthesis • Interference with metabolism • Impairment of nucleic acids
  • 23. Gram positive vs. Gram negative bacteria 23
  • 24. 24
  • 25. 25
  • 26. 26
  • 27. • Peptidoglycan is a carbohydrate composed of alternating units of NAMA and NAGA. • The NAMA units have a peptide side chain which can be cross linked from the L-Lys residue to the terminal D-Ala-D-Ala link on a neighboring NAMA unit. 27
  • 28. 28
  • 29. 29
  • 30. •The cross linking reaction is catalyzed by a class of transpeptidases known as penicillin binding proteins •A critical part of the process is the recognition of the D-Ala-D-Ala sequence of the NAMA peptide side chain by the PBP. Interfering with this recognition disrupts the cell wall synthesis. •β-lactams mimic the structure of the D-Ala-D-Ala link and bind to the active site of PBPs, disrupting the cross-linking process. Transpeptidase Enzyme 30
  • 33. Beta-Lactam Antibiotics β-lactam ring •Contains a beta-lactam ring in their molecular structures. •Nitrogen is attached to the beta carbon relative to the carbonyl ring and hence the name. 33
  • 36. How do they work? 1. The β-lactam binds to Penicillin Binding Protein (PBP). 2. PBP is unable to crosslink peptidoglycan chains. 3. The bacteria is unable to synthesize a stable cell wall. 4. The bacteria is lysed. 36
  • 37. Mechanism of β-Lactam Drugs • The amide of the β-lactam ring is unusually reactive due to ring strain and a conformational arrangement which does not allow the lone pair of the nitrogen to interact with the double bond of the carbonyl. • β-Lactams acylate the hydroxyl group on the serine residue of PBP active site in an irreversible manner. • This reaction is further aided by the oxyanion hole, which stabilizes the tetrahedral intermediate and thereby reduces the transition state energy. 37
  • 38. Mechanism of β-Lactam Drugs The hydroxyl attacks the amide and forms a tetrahedral intermediate. 38
  • 39. Mechanism of β-Lactam Drugs The tetrahedral intermediate collapses, the amide bond is broken, and the nitrogen is reduced. 39
  • 40. Mechanism of β-Lactam Drugs The PBP is now covalently bound by the drug and cannot perform the cross linking action. 40
  • 43. Penicillin G • It is a drug of choice for infections caused by streptococci, meningococci, enterococci, penicillin - susceptible pneumococci, non-β-lactamase-producing staphylococci, T. pallidum and many other spirochetes, clostridium species, actinomyces, and other Gram - positive rods and non-β-lactamase-producing Gram- negative anaerobic organisms. 43
  • 44. Adverse effects •The main hazard with the penicillins is allergic reaction. •These include itching, rashes (eczematous or urticarial), fever, and angioedema. •Rarely (about 1 in 10 000) there is anaphylactic shock which can be fatal (about 1 in 50 000 – 100 000 treatment courses). 44
  • 45. • Allergies are least likely when penicillins are given orally and most likely with local application. • Metabolic opening of the β-lactam ring creates a highly reactive penicilloyl Group which polymerizes and binds with tissue Proteins to form the major antigenic determinant. • The anaphylactic reaction involves specific IgE antibodies which can be detected in the plasma of susceptible persons. 45
  • 47. PENICILLIN G 1. Sod. Penicillin G (crystalline penicillin) injection. 0.5-5 MU i.m/i.v 6-12 hourly. Available as dry powder to be dissolves with sterile water at the time of injection. 2. Procaine penicillin G inj. 0.5-5 MU i.m/i.v 12-24 hourly. 3. Benzathine penicillin G o.6-2.4 MU i.m. every 2-4 weeks as aqueous suspensions. 47
  • 48. Penicillin V (Phenoxymethylpenicillin) EFFECTIVE AGAINST: • Gram positive + Less effective against Gram negative bacteria TREATMENT FOR: • Tonsillitis • Anthrax • Rheumatic fever • Streptococcal skin infections CHARACTERISTICS: • Narrow spectrum • Should be given orally • Prone to beta-lactamase 48
  • 49. Jarisch – Herxheimer Reaction • Pencillin is injected into a syphilitic patient. • May produce shivering, fever, myalgia, exacerbation of the lesions and even vascular collapse. • Occurs due to sudden release of spirochetal lytic products. • Effects last for 12 – 72 hours. • Intake of Aspirin and sedation cause relief of symptoms. 49
  • 51. Ampicillin EFFECTIVE AGAINST: • Gram positive + Gram negative bacteria TREATMENT FOR: • Ear infection • Sinusitis • Urinary tract infections • Meningitis CHARACTERISTICS: • Broad spectrum • Can be given orally and parenterally • Prone to beta- lactamase Ampicillin Sulbactam + ll Unasyn 51
  • 52. Amoxicillin EFFECTIVE AGAINST: • Gram positive + Gram negative bacteria TREATMENT FOR: • Skin infection • Sinusitis • Urinary tract infections • Streptococcal pharyngitis CHARACTERISTICS: • Broad spectrum • Can be given orally and parenterally • Prone to beta-lactamase SIDE-EFFECTS: • Rash, diarrhea, vomiting, nausea, edema, stomatitis, and easy fatigue. Amoxicillin Clavulanic Acid + ll Augmentin 52
  • 54. Methicillin EFFECTIVE AGAINST: • Gram positive bacteria TREATMENT FOR: • Cellulitis • Also for life threating diseases such as pneumonia, endocarditis, bacteremia and meningitis. CHARACTERISTICS: • Very narrow Spectrum • Should be given parenterally SIDE-EFFECT: • Interstitial nephritis 54
  • 55. Oxacillin EFFECTIVE AGAINST: • Gram positive bacteria TREATMENT AGAINST: • penicillin-resistant Staphylococcus aureus CHARACTERISTICS: • Very narrow Spectrum • Should be given parenterally SIDE-EFFECT: • Hypersensitivity and local reactions • In high doses, renal, hepatic, or nervous system effects can occur 55
  • 56. Nafcillin EFFECTIVE AGAINST: • Gram positive bacteria TREATMENT AGAINST: • Staphylococcal infections CHARACTERISTICS: • Very narrow Spectrum • Should be given parenterally SIDE-EFFECT: • Allergic reactions • Nausea and vomiting • Abdominal pain 56
  • 57. Cloxacillin EFFECTIVE AGAINST: • Staphylococci that produce beta-lactamase CHARACTERISTICS: • Very narrow Spectrum • Should be given orally SIDE-EFFECT: • Allergic reaction 57
  • 58. Dicloxacillin EFFECTIVE AGAINST: • Gram positive bacteria + Staphylococci that produce beta- lactamase CHARACTERISTICS: • Very narrow Spectrum • Should be given orally SIDE-EFFECT: • Allergic reaction • Diarrhoea, nausea, rash, urticaria pain and inflammation at injection site 58
  • 59. Flucloxacillin EFFECTIVE AGAINST: • Gram positive bacteria + Staphylococci that produce beta- lactamase CHARACTERISTICS: • Very narrow Spectrum • Should be given orally SIDE-EFFECT: • Allergic reaction • Diarrhoea, nausea, rash, urticaria pain and inflammation at injection site 59
  • 61. Piperacillin EFFECTIVE AGAINST: • Gram positive +Gram negative CHARACTERISTICS: • Extended Spectrum • Should be given by intravenous or intramuscular injection SIDE-EFFECT: • Hypersensitivity • Gastrointestinal disorders • Renal disorders *Piperacillin+Tazobactam=Zosyn 61
  • 62. Carbenicillin EFFECTIVE AGAINST: • Gram negative + Limited Gram positive TREATMENT FOR: • Urinary tract infections CHARACTERISTICS: • Highly soluble in water and acid- labile SIDE-EFFECT: • High doses can cause bleeding • Hypokalemia 62
  • 63. Ticarcillin EFFECTIVE AGAINST: • Mainly gram negative bacteria particularly Pseudomonas aeruginosa TREATMENT FOR: • Stenotrophomonas maltophilia infections CHARACTERISTICS: SIDE-EFFECT: • Diarrhoea • Bleeding • Fever • Fainting 63
  • 65. 65
  • 66. • These has been conventionally classified into four generations based on Generation system. • This is based on chronological sequence of development, but more importantly, takes into consideration the overall antibacterial spectrum as well as potency. • First-generation cephalosporins are predominantly active against Gram-positive bacteria, and successive generations have increased activity against Gram-negative bacteria (albeit often with reduced activity against Gram-positive organisms). 66
  • 67. CEPHALOSPORINS •The nucleus of the cephalosporins, 7-aminocephalo- sporanic acid, bears a close resemblance to 6-amino- penicillanic acid. •The intrinsic antimicrobial activity of natural cephalosporins is low, but the attachment of various R1 and R2 groups has yielded hundreds of potent compounds of low toxicity. •Cephalosporins can be classified into four major groups or generations, depending mainly on the spectrum of their antimicrobial activity. 67
  • 69. Cephalosporins are similar to penicillins, but more stable to many bacterial beta-lactamases and therefore have a broader spectrum of activity. Klebsiella pneumoniae 69
  • 70. • However, strains of E. coli and Klebsiella species expressing extended-spectrum beta-lactamases that can hydrolyze most cephalosporins are becoming a problem. • Cephalosporins are not active against enterococci and Listeria monocytogenes. 70
  • 71. First Generation Cephalosporins Cefalothin Cefalexin Cefadroxil Cefazolin 71
  • 72. • These drugs are very active against Gram-positive cocci (such as pneumococci, streptococci, and Staphylococci). Cephalosporins are not active against methicillin- resistant strains of staphylococci. 72
  • 73. • E. coli, K. pneumoniae, and P. mirabilis are often sensitive. Anaerobic cocci (e.g., peptococcus, peptostreptococcus) are usually sensitive, but Bacteroides fragilis is not. 73
  • 75. Although the first-generation cephalosporins are broad spectrum and relatively nontoxic, they are rarely the drug of choice for any infection. 75
  • 77. • In general, they are active against organisms inhibited by first- generation drugs, but in addition they have extended Gram- negative coverage. • Klebsiellae (including those resistant to cefalothin) are usually sensitive. Cefamandole, cefuroxime, and cefaclor are active against H. influenzae but not against serratia or B. fragilis. 77
  • 78. • In contrast, cefoxitin, and cefotetan are active against B. fragilis and some serratia strains but are less active against H. influenzae. As with first-generation agents, none is active against enterococci or P. aeruginosa. 78
  • 81. Third Generation Cephalosporins Cefotaxime Ceftriaxone Ceftazidime 81
  • 82. • Compared with second-generation agents, these drugs have expanded Gram-negative coverage. • Third-generation drugs are active against Citrobacter, Serratia marcescens, and Providencia. • They are also effective against β-lactamase-producing strains of Haemophilus and Neisseria. 82
  • 83. Like the second-generation drugs, third-generation cephalosporins are hydrolyzable by constitutively produced beta-lactamase, and they are not reliably active against enterobacter species. 83
  • 84. Third-generation cephalosporins are used to treat a wide variety of serious infections caused by organisms that are resistant to most other drugs. 84
  • 88. • Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity. • They have a structure that renders them highly resistant to beta- lactamases. • Carbapenem antibiotics were originally developed from thienamycin, a naturally-derived product of Streptomyces cattleya. 88
  • 89. Carbapenems common uses • Imipenem • Broad spectrum, covers Gram-positive, Gram-negative (including ESBL-producing strains), Pseudomonas and anaerobes • Meropenem • Less seizure-inducing potential, can be used to treat CNS infections • Ertapenem • Lacks activity against Acinetobacter and Pseudomonas • Has limited activity against penicillin-resistant pneumococci 89
  • 90. Imipenem EFFECTIVE AGAINST: • Aerobic and anaerobic, Gram positive and gram negative bacteria CHARACTERISTICS: • Broad Spectrum • Intravenous • Resistant to beta-lactamase enzymes SIDE-EFFECT: • Seizuregenic at high doses 90
  • 91. Meropenem EFFECTIVE AGAINST: • Aerobic and anaerobic, Gram positive and gram negative bacteria CHARACTERISTICS: • Ultra Broad Spectrum • Intravenous • Resistant to beta-lactamase enzymes SIDE-EFFECT: • Diarrhoea • Vomiting • headache 91
  • 92. Ertapenem EFFECTIVE AGAINST: • Gram positive and gram negative bacteria CHARACTERISTICS: • Broad Spectrum • Intravenous • Resistant to beta-lactamase enzymes • Not active against MRSA SIDE-EFFECT: • Convulsions • Seizures • headache 92
  • 94. Aztreonam EFFECTIVE AGAINST: • Gram positive +Gram negative+Anaerobic bacteria CHARACTERISTICS: • Broad Spectrum • Intravenous • Resistant to beta-lactamase enzymes • Not active against MRSA SIDE-EFFECT: • Diarrhoea • Nausea • Vomiting 94
  • 95. BETA-LACTAMASE INHIBITORS • Resemble β-lactam antibiotic structure. • • Bind to β-lactamase and protect the antibiotic from destruction. • Most successful when they bind the β-lactamase irreversibly. • Three important in medicine: • Clavulanic Acid • Sulbactam • Tazobactam 95
  • 97. Resistance-The Global Battle.!!! What is Resistance? •Drug resistance refers to unresponsiveness of a microorganism to an antimicrobial agent. •Drug resistance are of two types: ---Natural Resistance ---Acquired Resistance 97
  • 98. Natural Resistance • Some microbes have always been resistant to certain anti- microbial agent. • They lack the metabolic process or the target side that is affected by particular drug. E.g: Gram negative bacilli are normally unaffected by Penicillin G. • M. tuberculosis is insensitive to Tetracyclines. • This type of resistance does not pose significant clinical problem. 98
  • 99. Acquired Resistance • It is the development of resistance by an organism which was sensitive before due to the use of antimicrobial agent over a period of time. • This can happen with any microbe and is a major clinical problem. • However, the development of resistance is dependent on the microorganism as well as the drug. 99
  • 101. APPLIED ASPECT 1. Penicillin hypersensitivity 2. Skin eruptions
  • 102. • Anaphylaxis: Anaphylaxis occurs in about 1 in 10,000 patients using penicillin, accounting for approximately 300 deaths per year in the United States. .
  • 103. • Management: While the triggering agent of an acute allergic reaction is variable, the approach to handling the emergency is similar in most cases. The dentist's primary responsibility in an allergic emergency is to stabilize the patient until he or she can be transferred to an emergency facility or until assistance arrives. 103
  • 104. Guidelines for sequencing of antibiotic therapy • Supplemental, subgingivally applied, broad-spectrum antiseptic agents may be used. • Periodontal abscesses may develop if systemic antibiotics are administered without mechanical debridement. 104
  • 105. Prescription of drugs • Prescription drugs are the fastest growing component of personal health expenditures. • Contributing to this are the increased FDA approvals of expensive and new drugs. • Antibiotics should be prescribed judiciously rather than zealously. • Judicious use of antimicrobial therapy mandates restrained rather than indiscriminate prescribing. 105
  • 106. Antibiotic sensitivity cultures… • Aim is to measure susceptibility of an isolate two range of antibiotics at the individual patient level for effective prescribing but also to assess emerging bacterial resistance patterns. 106
  • 107. Overprescribing…. • Excessive prescribing or over prescribing unnecessarily exposes the patient to increased financial costs as well as substantial risk of antibiotic complications and increased number of antibiotic resistant organisms in the general population. Eg: For healthy patients prophylactic antibiotics for routine periodontal surgery or extractions. 107
  • 108. Wrong choice of antibiotics • Prescribing a broad spectrum antibiotic when a narrow spectrum one would be sufficient or prescribing unnecessarily long courses of antibiotic therapy increases the risk of resistant bacterial strain development. • Bacterial resistance to a single antibiotic or to multiple groups frequently results from genetic transfer abilities of bacteria which allow them to create pathogens with antibiotic resistant genes. 108
  • 109. Antibiotics in periodontal therapy Conditions that may call for systemic antimicrobial periodontal therapy are: • Medical conditions that predispose patients to periodontitis. • Acute periodontal infections (periodontal abscess, acute necrotizing ulcerative gingivitis/periodontitis). 109
  • 110. Antibiotics in endodontic therapy • It has been well documented that infected root canals are polymicrobial in nature with several predominant anaerobic microorganisms. • The key to successful management of infections of endodontic origin is the chemomechanical debridement of the infected root canal system and drainage from both soft and hard tissues. 110
  • 111. Antibiotics for oral and maxillofacial infections Antibiotic prophylaxis • It is not possible to make recommendations regarding antibiotic prophylaxis for all clinical situations. • Antibiotic prophylaxis is the administration of antibiotics to patients who have no known infection for the purpose of preventing microbial colonozation and reducing the potential for post operative complications. 111
  • 113. 113
  • 114. 114
  • 115. • They play a very important role in : • Patients at risk of bactereamia-induced infections. • Patients with Pregnancy • Breast feeding patients • Secondary infections • Or any other medically compromised patients . 115
  • 116. • It is therefore important for the clinicians to have proper knowledge, ability monitor the effectiveness of prescribed antibiotics and consider changing the drug or the method of therapeutic management with antibiotics. 116
  • 117. Bibliography • K.D. TRIPATHI text book of pharmacology. • Antibiotic and antimicrobial use in dental practice: 2nd edn, Michael G. Newman. • Pharmacology an introductory text: Mary Kaye Asperheim, 6th edn. • Text book of pharmacology, 1st edn, H.L. Sharma. • Anti microbial therapy in periodontics. Slots J. • Text book of Peridontology: Carranza. 117
  • 118. 118

Notas del editor

  1. Adding the oxygen decreases the nucleophilicity of the carbonyl group, making penicillin V acid stable and orally viable
  2. Ampicillin is active against Gram-(+) bacteria including Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus (but not methicillin-resistant strains), and some Enterococci Ampicillin is relatively non-toxic. Its most common side effects include rash, diarrhea, nausea and vomiting.[4] In very rare cases it causes severe side effects such as anaphylaxis and Clostridium difficile diarrhea.
  3. Side effects are similar to those for other β-lactam antibiotics, including nausea, vomiting, rashes, and antibiotic-associated colitis. Loose bowel movements (diarrhea) may also occur. Rarer side effects include mental changes, lightheadedness, insomnia, confusion, anxiety, sensitivity to lights and sounds, and unclear thinking.
  4. Dicloxacillin is insensitive to beta-lactamase (also known as penicillinase) enzymes secreted by many penicillin-resistant bacteria. The presence of theisoxazolyl group on the side chain of the penicillin nucleus facilitates the β-lactamase resistance, since they are relatively intolerant of side-chain steric hindrance. Thus, it is able to bind to penicillin-binding proteins (PBPs) and inhibit peptidoglycan crosslinking, but is not bound by or inactivated by β-lactamases.
  5. Dicloxacillin is insensitive to beta-lactamase (also known as penicillinase) enzymes secreted by many penicillin-resistant bacteria. The presence of theisoxazolyl group on the side chain of the penicillin nucleus facilitates the β-lactamase resistance, since they are relatively intolerant of side-chain steric hindrance. Thus, it is able to bind to penicillin-binding proteins (PBPs) and inhibit peptidoglycan crosslinking, but is not bound by or inactivated by β-lactamases.
  6. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.
  7. Reistance by efflux mechanism
  8. Inactivated by ESBL(Extended Spectrum beta-lactamases